Perceptive Advisors LLC Cassava Sciences Inc Put Options Transaction History

Perceptive Advisors LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	BUY	$12.35 - $26.11 $2.26 Million - $4.78 Million	183,000 New	183,000 $2.26 Million
Q4 2022 Feb 14, 2023	BUY	$27.82 - $44.16 $4.17 Million - $6.62 Million	150,000 New	150,000 $4.43 Million
Q2 2022 Aug 15, 2022	BUY	$17.22 - $38.47 $1.72 Million - $3.85 Million	100,000 New	100,000 $2.81 Million
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $9.78 Million - $15.9 Million	-300,000 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $7.35 Million - $18.2 Million	200,000 Added 200.0%	300,000 $13.1 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $4.18 Million - $13.5 Million	100,000 New	100,000 $6.21 Million

201

13.9M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $110M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Perceptive Advisors LLC with notifications on news.